- Home
- DFDV vs COYA Comparison
DFDV vs COYA Comparison
Compare DFDV & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DFDV | COYA |
|---|---|---|
| Founded | 2018 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4M | 102.7M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DFDV | COYA |
|---|---|---|
| Price | $3.80 | $3.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $8.70 | ★ $15.21 |
| AVG Volume (30 Days) | ★ 1.4M | 121.3K |
| Earning Date | 11-11-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,099,660.00 | ★ $7,945,753.00 |
| Revenue This Year | $46.67 | N/A |
| Revenue Next Year | $37.97 | $387.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 4.82 | ★ 123.57 |
| 52 Week Low | $2.44 | $3.71 |
| 52 Week High | $11.55 | $6.62 |
Technical Indicators
Market Signals| Indicator | DFDV | COYA |
|---|---|---|
| Relative Strength Index (RSI) | 41.83 | 33.87 |
| Support Level | $3.11 | $3.88 |
| Resistance Level | $5.22 | $5.17 |
| Average True Range (ATR) | 0.33 | 0.28 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 30.67 | 4.39 |
Price Performance
Historical ComparisonAbout DFDV DeFi Development Corp.
DeFi Development Corp is a U.S. company committed to building its treasury around Solana (SOL), a fast-growing blockchain infrastructure platform. This equity delivers shareholders tangible exposure to SOL price movement and staking rewards, making the firm a proxy for the Solana ecosystem. The treasury extends to running its own validator infrastructure, allowing DFDV to actively participate in and benefit from the Solana network expansion. The firm has two segments: Digital Asset Treasury ("Treasury") and Real Estate Platform ("Real Estate"). The company generates the majority of its revenue from the Treasury segment.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.